Cellistic, a cell therapy development and manufacturing company, agreed to acquire the manufacturing business unit of Celyad Oncology, a clinical-stage biotechnology company. Financial terms were not disclosed. “We at Cellistic are incredibly excited to welcome this uniquely talented team into our organization. We’re bringing aboard a group of people whose passion and capabilities align incredibly well with our vision for the future of cell therapy. As a joined force, we have the talent and resources to further accelerate work on our proprietary platforms and the capability to enable Cellistic’s partners to bring iPSC-based allogeneic cell therapies to patients faster,” Stefan Braam, Cellistic Founder and CEO.